Stock DLCL6 DR LALCHANDANI LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dr Lalchandani Labs Limited

Equities

DLCL6

INE871Z01013

Healthcare Facilities & Services

Market Closed - Bombay S.E.
Other stock markets
 06:00:54 2024-05-21 am EDT 		5-day change 1st Jan Change
22.81 INR +4.16% Intraday chart for Dr Lalchandani Labs Limited +8.62% +7.44%
May. 02 Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer CI
Apr. 06 Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer CI

Valuation

Fiscal Period: März 2019 2020 2021 2022 2023
Capitalization 1 84.49 35.14 60.23 143 123.1
Enterprise Value (EV) 1 73.3 30.2 71.69 159.1 155
P/E ratio 15.9 x 7.44 x 5.97 x 15.3 x -7.87 x
Yield - - - - -
Capitalization / Revenue 1.61 x 0.58 x 0.62 x 1.27 x 2.44 x
EV / Revenue 1.39 x 0.49 x 0.73 x 1.41 x 3.08 x
EV / EBITDA 6.25 x 2.45 x 3.29 x 6.65 x 886 x
EV / FCF -4.48 x -3.71 x -5.67 x -39.1 x -13 x
FCF Yield -22.3% -26.9% -17.6% -2.56% -7.69%
Price to Book 1.05 x 0.41 x 0.63 x 1.36 x 1.38 x
Nbr of stocks (in thousands) 4,333 4,333 4,333 4,333 4,333
Reference price 2 19.50 8.110 13.90 33.00 28.41
Announcement Date 9/7/19 9/7/20 9/7/21 9/8/22 9/8/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net sales 1 28.07 52.61 61.04 97.8 112.8 50.4
EBITDA 1 6.333 11.74 12.32 21.78 23.94 0.175
EBIT 1 5.061 8.496 8.457 17.03 18.84 -5.736
Operating Margin 18.03% 16.15% 13.86% 17.42% 16.7% -11.38%
Earnings before Tax (EBT) 1 3.546 7.19 6.608 13.77 12.87 -15.63
Net income 1 2.624 5.335 4.742 10.11 9.333 -15.63
Net margin 9.35% 10.14% 7.77% 10.34% 8.27% -31.01%
EPS 2 0.8900 1.230 1.090 2.330 2.150 -3.610
Free Cash Flow 1 -7.189 -16.35 -8.131 -12.63 -4.073 -11.93
FCF margin -25.61% -31.09% -13.32% -12.92% -3.61% -23.67%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/13/18 9/7/19 9/7/20 9/7/21 9/8/22 9/8/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 9.66 - - 11.5 16.1 31.9
Net Cash position 1 - 11.2 4.94 - - -
Leverage (Debt/EBITDA) 1.525 x - - 0.5261 x 0.673 x 182.4 x
Free Cash Flow 1 -7.19 -16.4 -8.13 -12.6 -4.07 -11.9
ROE (net income / shareholders' equity) 12.3% 9.36% 5.71% 11.2% 9.32% -16.1%
ROA (Net income/ Total Assets) 6.35% 6.5% 4.79% 7.85% 7.07% -2%
Assets 1 41.33 82.14 99.04 128.9 132.1 781.2
Book Value Per Share 2 11.40 18.60 19.70 22.00 24.20 20.60
Cash Flow per Share 2 3.100 4.670 5.200 6.680 8.150 7.160
Capex 1 13 15.7 6.14 22.9 11 3.05
Capex / Sales 46.16% 29.86% 10.06% 23.39% 9.71% 6.05%
Announcement Date 11/13/18 9/7/19 9/7/20 9/7/21 9/8/22 9/8/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
DR LALCHANDANI LABS LIMITED Stock Dr Lalchandani Labs Limited
+7.44% 1.19M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-23.47% 8.01B
RADNET, INC. Stock RadNet, Inc.
+68.45% 4.3B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+0.32% 2.55B
SYNLAB AG Stock SYNLAB AG
-8.93% 2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.22% 2.44B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-8.90% 1.89B
FLEURY S.A. Stock Fleury S.A.
-18.96% 1.59B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.70% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+13.38% 1.17B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. DLCL6 Stock
  4. Financials Dr Lalchandani Labs Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW